Concepedia

Publication | Open Access

Gemcitabine versus bacille Calmette‐Guérin after initial bacille Calmette‐Guérin failure in non‐muscle‐invasive bladder cancer

180

Citations

16

References

2010

Year

Abstract

Gemcitabine might represent a second-line treatment option after BCG failure in high-risk non-muscle-invasive BC patients.

References

YearCitations

Page 1